Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dietary Fish Oil Intervention in Polycystic Ovary Syndrome
NCT04116203Phase 1Completed
- Sponsor
- University of Alberta
- Start
- Jun 2016
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of fish oil concentrate in polycystic ovary syndrome (PCOS) and lipid metabolism disorder (3 arms), sponsored by University of Alberta. Primary endpoints: Plasma Triglycerides in non-fasting and fasted state at 12 weeks and apoB-lipoprotein remnants in non-fasting and fasted state at 12 weeks. Started Jun 2016; status: completed.
02
Drugs
fish oil concentrate
03
Conditions
polycystic ovary syndrome (PCOS)lipid metabolism disorder
Beyond the preview
Go deeper on NCT04116203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04116203.